Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has provided an update.
Fuso Pharmaceutical Industries, Ltd. announced corrections to its financial results for the fiscal year ended March 31, 2025, due to a provision for litigation losses related to a patent infringement lawsuit. This adjustment significantly impacts the company’s financial statements, resulting in an extraordinary loss for fiscal year 2024 and necessitating revisions to key financial documents.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is involved in providing healthcare solutions.
Average Trading Volume: 24,093
Technical Sentiment Signal: Buy
Current Market Cap: Yen19.95B
See more data about 4538 stock on TipRanks’ Stock Analysis page.